The ongoing improvement at cessation of treatment at day 54 shows potential for further benefit hopefully compassionate use will be available next, to allow Retts patients and their family's the benefit of this significant and apparently sustained improvement
- Forums
- ASX - By Stock
- Ann: Trofinetide significant clinical benefit in Rett syndrome
The ongoing improvement at cessation of treatment at day 54...
-
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$17.09 |
Change
0.000(0.00%) |
Mkt cap ! $2.184B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8 | $18.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.00 | 3429 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8 | 18.000 |
2 | 582 | 17.950 |
2 | 650 | 17.500 |
1 | 100 | 17.150 |
2 | 3116 | 17.100 |
Price($) | Vol. | No. |
---|---|---|
15.000 | 3429 | 4 |
15.400 | 15 | 1 |
15.500 | 2500 | 1 |
15.800 | 1425 | 1 |
16.000 | 7061 | 2 |
Last trade - 16.16pm 08/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
Day chart unavailable